Table 2 Key Components of the CDS tool. The question was: How do you personally evaluate the importance of the following components/factors in a CDS tool that can assist you in prescribing decisions for older patients (65 years or older)?
Questions and Answers | Percentage |
|---|---|
Components based on the American Geriatrics Society (AGS) recommendations | |
1. Patient's remaining life expectancy | |
Not at all important to slightly important | 3% |
Important to very important | 97% |
2. Patient's level of independence and functional capacity | |
Not at all important to slightly important | 2% |
Important to very important | 98% |
3. Patient's quality of life | |
Not at all important to slightly important | 0% |
Important to very important | 100% |
Patient-related factors | |
4. Patient's living situation (living alone, with family, or living in a nursing home) | |
Not at all important to slightly important | 15% |
Important to very important | 85% |
5. The involvement of patient's family in taking care of the patient | |
Not at all important to slightly important | 23% |
Important to very important | 77% |
6. Patient's financial status | |
Not at all important to slightly important | 27% |
Important to very important | 73% |
7. Patient's willingness to adhere to therapy | |
Not at all important to slightly important | 5% |
Important to very important | 95% |
8. Patient's history of adherence to drug therapy | |
Not at all important to slightly important | 6% |
Important to very important | 94% |
9. Patient's risk to develop a potential adverse drug reaction due to therapy | |
Not at all important to slightly important | 5% |
Important to very important | 95% |
10. The goal of therapy (curative, palliative, for symptoms relief, to prevent fatal events or to prolong life)] | |
Not at all important to slightly important | 0% |
Important to very important | 100% |
Medication-related factors | |
11. Cost of therapy | |
Not at all important to slightly important | 13% |
Important to very important | 87% |
12. Level of evidence of therapy's efficacy | |
Not at all important to slightly important | 0% |
Important to very important | 100% |
13. The effectiveness of the medication (e.g., how much it reduces HbA1c) | |
Not at all important to slightly important | 4% |
Important to very important | 96% |
14. Level of evidence of therapy's safety | |
Not at all important to slightly important | 0% |
Important to very important | 100% |
15. Safety profile of the medication | |
Not at all important to slightly important | 0% |
Important to very important | 100% |